ACELRX PHARMACEUT. DL-01 (R5XA) — Cash Flow Quality Index
ACELRX PHARMACEUT. DL-01 (R5XA) has a Cash Flow Quality Index of -0.67x as of December 2022. Operating cash flow of €-28.33 Million is below net income of €42.33 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore R5XA operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
ACELRX PHARMACEUT. DL-01 Cash Flow Quality Index (2022–2022)
Historical Cash Flow Quality Index for ACELRX PHARMACEUT. DL-01 across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see ACELRX PHARMACEUT. DL-01 cash flow conversion.
Annual Cash Flow Quality Index for ACELRX PHARMACEUT. DL-01 (2022–2022)
Year-by-year earnings quality comparison for ACELRX PHARMACEUT. DL-01.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | -0.67x | €-28.33 Million | €42.33 Million | — |